Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2024 (4)
  • 2023 (11)
  • 2022 (17)
  • 2021 (18)

Subject

  • Drug Trafficking (204)
  • Seizures (Drugs/Property) (176)
  • Synthetic drugs (166)
  • Task Forces/Task Force Officers (161)
  • Major Law Enforcement Operation (122)
  • Guns/Weapons (91)
  • OCDETF/Task Force (80)
  • Overdose (65)
  • Arrests/Convictions - Major (58)
  • Gangs (47)
  • Fake Pills (46)
  • Prescription Drugs (41)
  • Narcoterrorism (36)
  • Pharmaceuticals/Pharmacists/Physicians (34)
  • Guilty Plea (31)
  • Press Conferences (20)
  • Money Laundering (17)
  • One Pill Can Kill (10)
  • HIDTA (9)
  • Public and Media Affairs - also see Congressional Affairs (8)
  • Dark Web- Internet Trafficking (7)
  • Fentanyl Awareness (7)
  • Prevention/Education - DEA websites GSAD, JTT etc (7)
  • Take Back Day (7)
  • International/Foreign Operations (6)
  • Asset Forfeiture (5)
  • Extraditions (3)
  • Intergovernmental Affairs (2)
  • Museum and Visitors Center (2)
  • Intelligence Division - Intelligence Products (1)
  • Diversion Division (30)
  • Outreach/Drug Prevention (24)

Drug Name

  • Opioids (30)
  • Synthetic Opioids (19)
  • Fentanyl (18)
  • Oxycodone (11)
  • Methamphetamine (5)
  • Benzodiazepines (4)
  • Hydromorphone (4)
  • Steroids (3)
  • Cocaine (2)
  • Marijuana (Cannabis) (2)
  • Morphine (2)
  • Amphetamines (1)
  • Methadone (1)

Field Division

  • New England (30)
  • Omaha (29)
  • Seattle (28)
  • New York (25)
  • Sede (25)
  • Chicago (20)
  • El Paso (16)
  • Houston (16)
  • New Jersey (16)
  • New Orleans (14)
  • Atlanta (13)
  • Miami (13)
  • Rocky Mountain (13)
  • St. Louis (13)
  • San Diego (7)
  • Dallas (6)
  • Los Angeles (6)
  • Phoenix (6)
  • Detroit (4)
  • San Francisco (4)
  • Philadelphia (3)
  • Louisville (2)
  • Washington, DC (50)
Clear All Results
PRESS RELEASE

U.S. Attorney’s Office and DEA Announce Fatal Fentanyl Overdose Task Force

Octubre 28, 2024
Baltimore, Maryland – Erek L. Barron, U.S. Attorney for the District of Maryland and Jarod Forget, Special Agent in Charge of the Drug Enforcement Administration’s (DEA) Washington Division, announced that their agencies have formed the Maryland Fatal Fentanyl Overdose Task Force (“MFFOTF”). The alarming rate of overdoses in Maryland has...
Octubre 28, 2024
PRESS RELEASE

DEA Washington Division Calls on the Community to Have Important Conversations on Dangers of Drugs and Fake Pills in Back-To-School Routines

Agosto 22, 2024
Washington, DC – As schools in the District of Columbia, Maryland, and Virginia open their doors to students and teachers this month, the Drug Enforcement Administration (DEA) Washington Division is urging the community to have important conversations about the consequences of drug experimentation and misuse as the new school year...
Agosto 22, 2024
PRESS RELEASE

Powerful Stories and Connections During DEA Washington Division’s 3rd Family Summit on Fentanyl

Junio 24, 2024
WASHINGTON, DC – On June 18, the Drug Enforcement Administration (DEA) Washington Division hosted their 3rd Family Summit in support of those who have lost loved ones to fentanyl poisoning in the District of Columbia, Maryland, and Virginia (DMV). In alignment with DEA's mission, the event aimed to provide opportunities...
Junio 24, 2024
PRESS RELEASE

DEA Washington Division Saw a Surge of Over 250% in Fentanyl Pill Seizures in 2023

Enero 26, 2024
Washington, DC – The Drug Enforcement Administration’s (DEA) Washington Division, which covers the District of Columbia, Maryland, and Virginia (DMV) confiscated more than 639,000 fentanyl pills and 189 pounds of fentanyl powder in 2023. This amount represents more than a three-fold increase in the number of fake pills laced with...
Enero 26, 2024
PRESS RELEASE

DEA’s National Prescription Drug Take Day Removes Almost 600,000 Pounds of Unneeded Prescription Medications Across the Country

Noviembre 08, 2023
WASHINGTON, DC – On October 28, 2023, the community once again emptied their medicine cabinets to help dispose of old, unwanted, and expired medications. Nationwide, DEA and its law enforcement partners collected 599,897 pounds of unneeded medications at 4,675 collection sites nationwide. Locally, the Washington Division, which includes the District...
Noviembre 08, 2023
PRESS RELEASE

DEA Washington Division is Ready to Celebrate the 25th National Drug Take Back Day Across the DMV

Octubre 16, 2023
Washington, DC – The Drug Enforcement Administration (DEA) will host its 25th National Prescription Drug Take Back Day on Saturday, October 28, from 10 a.m. to 2 p.m. in more than 300 collection sites across Maryland, District of Columbia, and Virginia (DMV). Through a collaborative effort with local law enforcement...
Octubre 16, 2023
PRESS RELEASE

DEA Washington Division Holds Second Annual Family Summit on Fentanyl

Octubre 13, 2023
WASHINGTON, DC – On October 6, the Drug Enforcement Administration (DEA) Washington Division hosted their 2nd Family Summit in support of those who have lost loved ones to fentanyl poisoning in the District of Columbia, Maryland, and Virginia. The Summit was very emotional and educational to all those who attended...
Octubre 13, 2023
PRESS RELEASE

Former Chief Operating Officer of Area Pain Clinics Indicted

Septiembre 29, 2023
CHARLOTTESVLLE, Va. – A federal grand jury returned an indictment this week charging the former chief operating officer of area pain clinics with three conspiracy counts for her alleged involvement in health care fraud and illegal drug distribution. Jennifer Ann “Jen” Adams, 50, of Mount Pleasant, South Carolina, is charged...
Septiembre 29, 2023
PRESS RELEASE

Consent Decree Approved Among the U.S. and Cumberland, M.D. based Pharmacy and Pharmacist

Julio 06, 2023
Baltimore, Maryland - U.S. District Judge Lydia K. Griggsby approved the United States’ consent decree with John A. Beckman, a Cumberland, Maryland based pharmacist, and Beckman’s Greene Street Pharmacy, Inc. (“Beckman’s Pharmacy”), resolving the United States’ civil allegations that Beckman and Beckman’s Pharmacy violated the Controlled Substances Act (“CSA”) in...
Julio 06, 2023
PRESS RELEASE

The United States and Montgomery County Based Pharmacy and Pharmacist Reach a Consent Decree Over Allegations of Illegally Dispensed Controlled Substances

Mayo 31, 2023
Greenbelt, Maryland - U.S. District Judge Peter J. Messitte approved the United States’ consent decree with Abtin Youssefi-Rashti, a Montgomery County based pharmacist, and Upton Care Pharmacy, Inc. (“Upton Care”), resolving the United States’ civil allegations that Youssefi-Rashti and Upton Care violated the Controlled Substances Act (“CSA”) in illegally dispensing...
Mayo 31, 2023
Showing 1 - 10 of 50 results

Paginación

  • Current page 1
  • Página 2
  • Página 3
  • Página 4
  • Página 5
  • Siguiente página ›
  • Última página »

SAMHSA Behavioral Health Treatment Locator

  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster

United States Drug Enforcement Administration

Back
  • Quiénes somos
  • Recursos
Back
  • Sobre la DEA
  • Mission
  • Nuestra historia
  • Divisiones Nacionales
  • DEA Museum
  • Wall of Honor
  • Contáctenos
Back
  • Operational Divisions
Back
  • Submit a Tip
  • Extortion Scam
  • Public Affairs
  • Social Media Directory
Back
  • Illegal Online Pharmacies
  • OD Justice
  • Fentanyl Supply Chain
  • Pill Press Resources
  • Recovery Resources
  • Together for Families
  • Ley de Libertad de Información
  • Publications
  • Galerías Multimedia
  • Programa de Asistencia a Testigos para Víctimas
Back
  • Fee Waiver
Back
  • Human Trafficking Prevention
  • Submit A Tip +
  • Get Updates
  • Scam Alert
    • English
    • Español